Diet exercise.

HbA1c of 6.4% is in the prediabetes range. Lifestyle modification remains the foundation of treatment and if medication is required, metformin alone is usually the first choice in appropriate patients. The addition of sitagliptin should be based on the treating physician’s overall clinical assessment. Since the patient is 72 years old with compensated liver cirrhosis, treatment should be individualized to avoid overtreatment. Persistent high blood pressure also needs prompt evaluation and optimization, as controlling BP is equally important in reducing the risk of heart, brain and kidney complications. An endocrinology review would be helpful before increasing the diabetes medication.

If. HBA1c is 6.4 with already taking Sitagliptin/Metformin it’s not Pre diabetes

At HbA1c 6.4 (prediabetes), Metformin 500mg alone once daily is the standard pharmacological choice per ADA guidelines — the combination with Sitagliptin is typically reserved for Type 2 Diabetes, not prediabetes. That said, Sitagliptin/Metformin 50/500 once daily is a low dose and not inherently dangerous — it carries minimal hypoglycemia risk since DPP-4 inhibitors (sitagliptin) rarely cause low blood sugar on their own. However, increasing the dose is NOT advisable at HbA1c 6.4 with normal FBS — this risks over-treatment, especially in a 72-year-old weighing only 52kg. Regarding liver cirrhosis: Metformin is cautiously acceptable in early compensated cirrhosis with normal creatinine, but needs regular monitoring. Sitagliptin is generally safer in liver disease than metformin. The current dose (once daily, low strength) is unlikely to cause harm, but the priority at this stage should be lifestyle measures — diet control and walking — with medication as a supporting role, not the primary treatment.

A combination tablet of sitagliptin and metformin is generally not the standard first-line choice for managing isolated prediabetes (HbA1c of 6.4%). While metformin alone is frequently used off-label to prevent the progression to type 2 diabetes, sitagliptin (a DPP-4 inhibitor) is typically reserved for the treatment of established type 2 diabetes. The patient has early compensated liver cirrhosis. While metformin is often safe in stable, compensated liver disease, it must be monitored closely due to the theoretical risk of lactic acidosis if liver function declines. Furthermore, certain medications require careful dose adjustments in patients with hepatic impairment. Given these factors, increasing the dose of a combination therapy for a patient strictly in the prediabetic range warrant a detailed second opinion from a gastroenterologist or hepatologist alongside a primary care physician to ensure it aligns safely with her liver status.

Yes with diet and exercise no medicibes needed

Avoid fried and spicy food Water intake more Green leafy vegetables more Fiber meal. Walk Do connect and consult Will help you

Need a few more details please consult for further evaluation and treatment

Pl try Diet control, Ealing, life style modification, and metformin. Pl have regular follow up.

Hello If HbA1c is less than 6.5 , you can continue the same . Some dietary modifications like eating low glycemic index food might be helpful . What about cholesterol levels ? Is that normal ?

Not required

Yes,risky

No , but adv dietary control with exercise